2 assets in Malignant Hypertension

Therapeutic assets addressing Malignant Hypertension, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Labetalol Malignant Hypertension	Haseki Training and Research Hospital	P4	BB (69)
Nicardipine Malignant Hypertension	Haseki Training and Research Hospital	P4	BB (69)